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Abstract
Context: It is well established that autologous chondrocyte implantation (ACI) can require extended recovery postoperatively; 
however, little information exists to provide clinicians and patients with a timeline for antici- pated function during the first year after 
ACI. Objective: To document the recovery of functional performance of activities of daily living after ACI. Patients: ACI patients (n = 
48, 29 male; 35.1 ± 8.0 y). Intervention: All patients completed functional tests (weight-bearing squat, walk-across, sit-to-stand, step-
up/over, and forward lunge) using the NeuroCom long force plate (Clackamas, OR) and completed patient-reported outcome 
measures (International Knee Documentation Committee Subjective Knee Evaluation Form, Lysholm, Western Ontario and McMaster 
Osteoarthritis Index [WOMAC], and 36-Item Short-Form Health Survey) preoperatively and 3, 6, and 12 mo postoperatively. Main 
Outcome Measures: A covariance pattern model was used to compare performance and self-reported outcome across time and provide 
a timeline for functional recovery after ACI. Results: Participants demonstrated significant improvement in walk-across stride length 
from baseline (42.0% ± 8.9% height) at 6 (46.8% ± 8.1%) and 12 mo (46.6% ± 7.6%). Weight bearing on the involved limb during 
squatting at 30°, 60°, and 90° was significantly less at 3 mo than presurgery. Step-up/over time was significantly slower at 3 mo (1.67 ± 
0.69 s) than at baseline (1.49 ± 0.33 s), 6 mo (1.51 ± 0.36 s), and 12 mo (1.40 ± 0.26 s). Step-up/over lift-up index was increased from 
baseline (41.0% ± 11.3% body weight [BW]) at 3 (45.0% ± 11.7% BW), 6 (47.0% ± 11.3% BW), and 12 mo (47.3% ± 11.6% BW). 
Forward-lunge time was decreased at 3 mo (1.51 ± 0.44 s) compared with baseline (1.39 ± 0.43 s), 6 mo (1.32 ± 0.05 s), and 12 mo (1.27 
± 0.06). Similarly, forward-lunge impact force was decreased at 3 mo (22.2% ± 1.4% BW) compared with baseline (25.4% ± 1.5% BW). 
The WOMAC demonstrated significant improvements at 3 mo. All patient-reported outcomes were improved from baseline at 6 and 
12 mo postsurgery. Conclusions: Patients’ perceptions of improvements may outpace physical changes in function. Decreased function 
for at least the first 3 mo after ACI should be anticipated, and improvement in performance of tasks requiring weight-bearing knee 
flexion, such as squatting, going down stairs, or lunging, may not occur for a year or more after surgery.
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Context: It is well established that autologous chondrocyte implantation (ACI) can require extended recovery 
postoperatively; however, little information exists to provide clinicians and patients with a timeline for antici-
pated function during the first year after ACI. Objective: To document the recovery of functional performance 
of activities of daily living after ACI. Patients: ACI patients (n = 48, 29 male; 35.1 ± 8.0 y). Intervention: All 
patients completed functional tests (weight-bearing squat, walk-across, sit-to-stand, step-up/over, and forward 
lunge) using the NeuroCom long force plate (Clackamas, OR) and completed patient-reported outcome measures 
(International Knee Documentation Committee Subjective Knee Evaluation Form, Lysholm, Western Ontario 
and McMaster Osteoarthritis Index [WOMAC], and 36-Item Short-Form Health Survey) preoperatively and 
3, 6, and 12 mo postoperatively. Main Outcome Measures: A covariance pattern model was used to compare 
performance and self-reported outcome across time and provide a timeline for functional recovery after ACI. 
Results: Participants demonstrated significant improvement in walk-across stride length from baseline (42.0% 
± 8.9% height) at 6 (46.8% ± 8.1%) and 12 mo (46.6% ± 7.6%). Weight bearing on the involved limb during 
squatting at 30°, 60°, and 90° was significantly less at 3 mo than presurgery. Step-up/over time was significantly 
slower at 3 mo (1.67 ± 0.69 s) than at baseline (1.49 ± 0.33 s), 6 mo (1.51 ± 0.36 s), and 12 mo (1.40 ± 0.26 
s). Step-up/over lift-up index was increased from baseline (41.0% ± 11.3% body weight [BW]) at 3 (45.0% ± 
11.7% BW), 6 (47.0% ± 11.3% BW), and 12 mo (47.3% ± 11.6% BW). Forward-lunge time was decreased 
at 3 mo (1.51 ± 0.44 s) compared with baseline (1.39 ± 0.43 s), 6 mo (1.32 ± 0.05 s), and 12 mo (1.27 ± 0.06). 
Similarly, forward-lunge impact force was decreased at 3 mo (22.2% ± 1.4% BW) compared with baseline 
(25.4% ± 1.5% BW). The WOMAC demonstrated significant improvements at 3 mo. All patient-reported 
outcomes were improved from baseline at 6 and 12 mo postsurgery. Conclusions: Patients’ perceptions of 
improvements may outpace physical changes in function. Decreased function for at least the first 3 mo after 
ACI should be anticipated, and improvement in performance of tasks requiring weight-bearing knee flexion, 
such as squatting, going down stairs, or lunging, may not occur for a year or more after surgery.
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Autologous chondrocyte implantation (ACI)1 has 
become an acceptable and common treatment approach 
for the management of symptomatic articular cartilage 
defects.2 As research regarding ACI has advanced, siz-
able efforts have been made to evaluate both disease- and 
patient-oriented outcomes after ACI. Numerous studies 
have evaluated the use of patient-reported outcome (PRO) 
measures to document the recovery of function and return 
to activity after ACI.3–5 Meta-analyses of more than 43 
studies have revealed large effect sizes demonstrating 
significant improvement for a variety of PRO scores 
after ACI.5 PROs provide reliable and valid information 
regarding patients’ perceived function and health-related 
quality of life.6–13 An alternative to PROs is the use of 
performance-based assessments (PBAs) to document 
outcomes. PBAs provide a direct, objective measure of 
patient function and involve measures of performance 
such as time, distance, or force for specified tasks or 
movements. The relationship between PROs and PBAs 
has previously been reported as low to moderate among 
a variety of knee patients.14–19 This discordance may be 
due in part to the strong influence perceived pain may 
have on PROs. For example, PRO scores may increase 
even in the absence of improved function if a patient’s 
pain has been resolved.19–22 Recent research involving 
total-joint arthroplasty patients has provided further 
support for the inclusion of PBAs as part of a detailed 
outcomes-assessment protocol.18–20 Combining PROs 
with PBAs may provide a more complete picture of 
clinical outcomes after ACI than the use of either type 
of outcome in isolation.
Few studies have used PBAs to document the return 
of function after ACI. Most of those that have examined 
either very low-demand activity such as the 6-minute-
walk test23–27 or very high-demand activity via the single-
limb hop.28 No known studies have examined the timeline 
for return to function after ACI using low- to moderate-
demand PBAs that recreate the demands and stresses of 
common activities of daily living such as squatting, rising 
from sitting, or going up and down stairs, in addition to 
walking. A description of functional recovery during the 
first year after ACI is imperative to provide evidence for 
prescription of appropriate patient education, rehabilita-
tion protocols, and understanding of the recovery process. 
Therefore, the purpose of this study was to document 
serial changes in knee function over 1 year after ACI using 
both PROs and PBAs. We hypothesized that PROs would 
demonstrate significant improvement from baseline at 
all postoperative time points. We also hypothesized that 
PBA measures for walking, rising from sitting, stepping 
up and over, and lunging would demonstrate no improve-
ments at the 3-month time point followed, by progressive 
improvement at 6 months and 12 months compared with 
baseline measures of function.
Methods
Patients
Between July 2008 and July 2011 patients were prospec-
tively recruited from an active cartilage center. Inclusion 
criteria were planned ACI surgery to the medial or lateral 
femoral condyle, trochlea, or patella; willingness to 
participate; no uncorrectable contraindications to ACI 
such as extensive degenerative joint disease, insufficient 
meniscus, or unstable knee; and ability to ambulate with-
out use of assistive devices. There were no exclusions 
based on limb malalignment if the malalignment was 
corrected before or at the time of surgery via high tibial 
osteotomy or tibial tubercle transfer. Similarly, patients 
undergoing concomitant or staged ligament reconstruc-
tion to correct joint instability were also eligible for study 
participation.
A total of 50 patients (31 male, 19 female; 35.0 ± 7.9 
y; 180.34 ± 30.7 cm; 92.0 ± 20.6 kg) agreed to participate. 
During the enrollment period 4 patients were invited to 
take part in the study but declined to participate, resulting 
in an enrollment rate of 93% of eligible patients. Of the 
enrolled patients, 24 underwent ACI to the patellofemoral 
joint with a tibial tubercle transfer and the remaining 26 
underwent ACI to the femoral condyle, of whom 4 also 
had a concomitant high tibial osteotomy and 2 underwent 
concomitant meniscal transplantation. Mean number of 
defects treated per patient was 1.5 ± 0.6 with an average 
treatment area of 8.7 ± 6.8 cm2 (range 1.96–39.0 cm2). 
All participants signed a university-approved institutional 
review board consent form at the time of enrollment.
Procedures
Surgical Procedures and Rehabilitation. All patients 
underwent a 2-step ACI procedure performed by the 
same surgeon (C.L.). During the first procedure a lim-
ited chondroplasty was performed and the lesion was 
evaluated arthroscopically. At this time a biopsy was 
obtained from the intracondylar notch (100–200 mg car-
tilage). This sample was sent to a commercial laboratory, 
where it was cultured and expanded (Carticel, Genzyme 
Corp, Cambridge, MA). In a second surgical procedure, 
chondrocyte implantation was performed using a miniar-
throtomy. First the defect or defects were prepared using 
a curette to debride down to the subchondral plate with 
stable edges. A type I/III collagen membrane (Bio-Gide®, 
Geistlich Biomaterials, Wohousen, Switzerland) was 
shaped to match the defect. Sutures and fibrin glue (Tis-
seel, Baxter Healthcare Corp, Deerfield, IL) were used to 
adhere the membrane over the defect to form a watertight 
seal. The chondrocytes in suspension were then injected 
beneath the membrane into the defect through a small 
portal remaining at the edge of the collagen membrane. 
The portal was then closed and sealed with sutures and 
additional fibrin glue.
All patients followed standardized rehabilitation 
protocols after surgery with considerations for defect 
location and concomitant procedures.29 All patients were 
braced in full extension and were non–weight bearing for 
2 weeks postoperatively. Toe-touch weight bearing was 
permitted from 2 to 4 weeks, with partial weight bearing 
from 4 to 6 weeks and progression to full weight bearing 
between weeks 6 and 12. Continuous passive motion 
was prescribed for all patients for 6 to 8 h/d for 6 weeks. 
For defects in the tibiofemoral joint, knee braces were 
gradually unlocked between 2 and 4 weeks as quadriceps 
control was gained. For defects to the patellofemoral 
joint, knees were braced in full extension for weight 
bearing through 4 weeks postoperative and then were 
gradually unlocked as quadriceps control was gained 
between weeks 4 and 6. Once good quadriceps control 
was gained, all patients were transitioned to a hinged 
knee sleeve. All patients were advised to abstain from 
high-intensity cutting or pivoting activity until at least 
12 months post-ACI.
Patient-Reported Outcomes. The PROs used in this 
study were the Medical Outcomes Study–36 Item 
Short Form Health Survey Physical Component Scales 
(SF-36 PCS),11,30,31 the Western Ontario and McMaster 
Osteoarthritis Index (WOMAC),10 the International 
Knee Documentation Committee (IKDC) Subjective 
Knee Evaluation Form,7 and the Lysholm Scale.32 The 
SF-36,13 IKDC,13 Lysholm,8 and WOMAC8,13 have all 
been evaluated for reliability among cartilage patients. A 
researcher independent of the treating physician reviewed 
each instrument with the patients and was available to 
answer any questions they may have had. All PROs were 
completed at the following time points: before implan-
tation (preoperation) and 3 months, 6 months, and 12 
months postsurgery.
Performance-Based Assessments. At each time point 
after completing PROs each participant completed a 
series of 5 PBAs in a musculoskeletal-laboratory setting. 
All PBAs were completed using the NeuroCom Balance 
Master and long force plate (NeuroCom International, 
Clackamas, OR). This is a commercially available 
system designed as both a training and an evaluation 
tool for function and balance tasks, and it has the ability 
to provide immediate feedback to clinicians and patients 
regarding quality of task performance for a variety of 
activities of daily living.33 The only exposure study par-
ticipants had with the long force plate was for research 
testing purposes, and they were not provided feedback 
during testing.
The long force plate consists of a 45.72 × 152.40-cm 
force plate with data sampled at 100 Hz and a personal 
computer equipped with data-capture software (Balance 
Master version 8.1). These functional tasks were selected 
because of their direct relationship to activities of daily 
living and the feasibility of patients’ being able to com-
plete the task at each testing time point (Table 1). Tests 
were completed in the order presented at all time points. 
This order was subjectively determined during pilot 
testing to be from least to most demanding. All testing 
was administered by the same investigator (J.S.H.). For 
all single-limb tests the uninvolved limb was tested first. 
Three successful trials of each task were performed 
(except for the weight-bearing squat, which consisted 
of a single trial at each joint angle). Approximately 15 
seconds of rest were permitted between trials and 30 
seconds of rest between tasks. For the purposes of this 
article, all outcome variables are identified using the 
names assigned to them by the software used. Definitions 
for these variables are presented in Table 1. The 5 tasks 
were as follows:
• Walk-Across (Figure 1): Patients walked across the
long force plate using their freely chosen standard
gait speed and pattern.
Table 1 Functional Tasks Evaluated on the NeuroCom Balance Master Long Force Plate
Task Parameters assessed
NeuroCom  
outcome variable Definition
Walk-across Characterization of gait Stride length (cm) Distance between contralateral heel strikes
Stride width (cm) Lateral distance between center of pressure (COP) of left and 
right foot strikes
Walking speed (cm/s) Speed of forward progression of the center of gravity 
Weight-bearing 
squat
Strength, weight 
distribution
% body weight (BW) at 0° 
(full extension), 30°, 60°, 
and 90° of knee flexion
% BW on the involved limb at each position (test duration 
0.01 s)
Sit-to-stand Strength, weight 
distribution, performance 
time, double limb balance
Weight-transfer time (s) Time required from start of motion while sitting (ie, increase 
in COP forward velocity by 5% from resting velocity) to 
achieve full weight-bearing standing (ie, forward velocity 
drops to within 5% of standing resting velocity)
Rising index (%BW) Peak vertical force exerted through the legs when rising to full 
standing relative to stationary vertical standing force
Weight symmetry % difference in weight supported by each limb during the 
weight-transfer phase
Step-up/over Concentric strength, 
eccentric control, 
performance time
Lift-up index (%BW) Peak vertical force occurring while stepping up onto the box 
as a percentage of BW
Impact index (%BW) Peak vertical force occurring while stepping down off the box 
as a percentage of BW
Movement time (s) Time between initial weight shift (ie, change in COP velocity 
by 5%) and contact with force plate on opposite side of 
box (determined by COP velocity dropping to within 5% of 
posttest resting velocity)
Lunge Concentric and eccentric 
control, functional range of 
motion, performance time
Distance (% subject 
height)
Length of lunge step as a percentage of subject height
Movement time (s) Duration of lunge phase during which lead leg is in contact with 
the force plate, start and stop of a trial determined by 5% change 
in COP velocity from pretest and posttest resting velocity
Impact index (%BW) Peak vertical force occurring during lunge maneuver as a 
percentage of BW
Note: All tasks were performed in the order presented by patients treated for articular cartilage defects to the knee.
• Weight-Bearing Squat (Figure 2): Patients stood
still on the force plate and force was recorded with
knee-flexion angles of 0°, 30°, 60°, and 90°. The
percentage of body weight on the involved limb was 
measured during a single trial with a duration of 0.01 
second for each position. A standard goniometer was
used to verify knee-joint angle at each position.
• Sit-to-Stand (Figure 3): Patients were seated on a
50-cm box. On both visual and audio signal from the
computer, they rose to full standing as quickly as pos-
sible without using their hands and then maintained
a steady stance for the remainder of the 10-second
trial.
• Step-Up/Over (Figure 4): Participants stood behind
a 29-cm-high box and stepped up onto the box with
their test leg, then brought their nontest leg up and
over the box, and then stepped down with their test
leg. Patients were instructed to complete this task as 
quickly as possible while still maintaining control.
Figure 1 — Walk-across. Outcome variables included stride 
width, stride length, and speed.
Figure 2 — Weight-bearing squat. Percentage of body weight on the involved limb was evaluated at 0° (not pictured), 30°, 60°, 
and 90° of knee flexion.
Figure 3 — Sit-to-stand. Beginning from a sitting position, participants were instructed, on receiving a visual and audio cue, to 
rise from sitting as quickly as possible without using hands to push off the box. Outcome measures included weight-transfer time, 
rising index, and weight symmetry.
Fi
g
u
re
 4
 —
 S
te
p-
up
/o
ve
r. 
B
eg
in
ni
ng
 w
ith
 b
ot
h 
fe
et
 b
eh
in
d 
th
e 
bo
x 
(n
ot
 p
ic
tu
re
d)
, p
ar
tic
ip
an
ts
 w
er
e 
in
st
ru
ct
ed
 to
 s
te
p 
up
 a
nd
 o
ve
r t
he
 b
ox
 a
nd
 re
tu
rn
 to
 s
ta
tio
na
ry
 s
ta
nd
in
g 
as
 q
ui
ck
ly
 
as
 th
ey
 c
ou
ld
 d
o 
so
 w
hi
le
 s
til
l m
ai
nt
ai
ni
ng
 c
on
tr
ol
. O
ut
co
m
e 
va
ri
ab
le
s 
w
er
e 
lif
t-
up
 in
de
x,
 im
pa
ct
 in
de
x,
 a
nd
 m
ov
em
en
t t
im
e.
• Forward Lunge: Patients in a standing position
stepped forward on 1 leg, squatted down as far as
possible, and then returned to the initial standing
position as quickly as possible.
Previous research has investigated the global compo-
nents of function assessed by the long force plate. Using 
factor-analysis methods, Chong34 identifi ed the latent 
functional variables assessed in several of the included 
tasks. He concluded that the sit-to-stand assessed the 
underlying factors of both agility and weight transfer, 
the step-up/over assessed force control, and the for-
ward lunge assessed the underlying factor of agility.34
In addition, walk-across stride width and stride length 
evaluated walking factors not well represented in the 
other functional tasks.34 Outcomes using the long force 
plate have also previously been reported for postoperative 
recovery after total knee replacement.19 Finally, the long 
force plate has been reported to be sensitive to functional 
defi cits after anterior cruciate ligament reconstruction.35
This existing literature supports the use of the long force 
plate as a useful tool for the assessment of lower extremity 
function, particularly among postoperative knee patients.
Statistical Analysis
A mixed-model analysis using a covariance pattern model 
with an autoregressive covariance matrix was used to 
compare changes in PROs and PBAs between preopera-
tive and 3-month, 6-month, and 12-month postoperative 
evaluations. Signifi cance level was set at P ≤ .05 a priori, 
and when a main effect was signifi cant, protected least-
signifi cant-difference pairwise comparisons were used 
to identify differences between individual time points.
Results
Six participants were declared clinical failures at or 
before the 1-year time point and were not medically 
cleared to complete functional testing at all follow-up 
time points; however, PRO scores were available for 4 of 
these patients, who had yet to undergo reoperation at the 
1-year time point. An additional 5 participants were lost 
to follow-up. All available data for all participants at all 
time points were incorporated into the statistical analysis.
Patient-Reported Outcomes
There was a main effect (P < .001) for time for all 4 PRO 
instruments (Figure 5). The WOMAC (P = .050) was the 
only instrument to show signifi cant changes between 
preoperation and the 3-month time point. There were 
signifi cant improvements from preoperation to the 6- and 
12-month follow-ups for the IKDC (P < .001, P < .001, 
respectively), SF36-PCS (P = .002, P = .001), Lysholm 
(P < .001, P < .001), and WOMAC (P < .001, P < .001).
Performance-Based Assessments
All PBAs demonstrated changes over time (Table 2). For 
the walk-across task there was a signifi cant increase in 
stride length observed at both the 6- and 12-month time 
points compared with preoperation (6-month, P = .002; 
Figure 5 — Patient-reported outcome scores. Abbreviations: IKDC, International Knee Documentation Committee Subjective 
Knee Evaluation Form; SF-35 PCS, 36-Item Short-Form Health Survey Physical Component Scales; WOMAC, Western Ontario and 
McMaster Osteoarthritis Index. IKDC and Lysholm are scored from 0 to 100, with 100 representing an ideal score. SF-36 PCS uses 
a norm-based scoring system where 50 represents a mean score with a standard deviation of 10 and higher scores represent higher 
levels of function. The WOMAC is scored from 96 to 0, with 0 representing no disability. Error bars represent standard deviations. 
*P ≤ .05 compared with preoperative time point.
12-month, P = .005) and when compared with 3-month 
values (6-month, P < .001; 12-month, P = .001). There 
was no main effect for time for stride width (P = .663) 
or walking speed (P = .051).
For the weight-bearing squat, a main effect for time 
was observed for squatting at 30° (P < .001), 60°, and 
90°. Post hoc analyses revealed decreases in weight 
distribution on the surgical limb between preoperation 
(48% body weight) and 3 months (43% body weight, P 
= .020) and 6 months (45% body weight, P = .020) for 
squatting at 30°. Decreased weight bearing was also 
observed between preoperation and 3 months (P < .001) 
and preoperation and 6 months (P = .048) for squatting 
at 60°. Similarly, squatting weight-distribution asym-
metries were observed at 90° relative to baseline at 3 
months (P < .001) Although not statistically different 
from preoperative values, at the 12-month time point 
mean weight distributions remained below preoperative 
values at 30°, 60°, and 90°.
The sit-to-stand demonstrated the earliest positive 
effects of surgery, with decreased weight-transfer time 
at 3 months (P = 0. 016) compared with preoperation. 
Weigh-transfer time continued to improve at 6 months 
(P = .05) and 12 months (P = .002).
For the step-up/over, there were significant increases 
in lift-up force between preoperation and the 3- (P = 
.003), 6- (P = .005), and 12-month (P = .010) follow-up 
time points. Time required to complete the step-up/over 
was also increased at 3months (P = .009) but returned 
to baseline at later time points. Similarly, step-up/over 
impact index was increased over preoperation values at 
3 months (P = .001) and 6 months (P = .034), possibly 
demonstrating a loss of eccentric control when stepping 
down from the box.
Finally, results for the forward lunge showed a sig-
nificant decrease in impact index (peak vertical ground-
reaction force) at 3 months (P = .007) but returned to 
preoperative levels and began to increase at the 6- and 
12-month time points. Similar to the step-up/over, 
forward-lunge time was slower at the 3-month time point 
(P = .006) but gradually became faster at subsequent 
evaluations.
Table 2 Patient-Reported and Performance-Based Assessments Over 12 Months After Autologous 
Chondrocyte Implantation, Mean (SD)
Test Preoperative 3 mo 6 mo 12 mo
Walk-across
width (% height) 10.1 (2.8) 9.7 (2.5) 9.7 (2.1) 9.5 (2.5)
length (%height) 42.0 (8.9) 42.1 (10.5) 46.8 (8.1)*† 46.9 (7.6)*†
speed (cm/s) 82.6 (16.8) 87.7 (24.6) 88.2 (19.3) 94.5 (18.2)
Double-limb squat (% BW)
 0° 48 (5) 48 (3) 49 (3) 49 (5)
 30° 48 (8) 43 (6)* 45 (6)* 46 (5)
 60° 47 (8) 42 (7)* 44 (6)* 45 (6)†
 90° 48 (6) † 44 (5)* 46† (6) 46 (6) †
Sit-to-stand
weight-transfer time (s) 0.51 (0.26) 0.39 (0.32)* 0.36 (0.19)* 0.33 (0.20)*
rise index (% BW > 100%) 23.3 (9.4) 22.0 (8.5) 24.0 (8.4) 24.6 (8.8)
involved/uninvolved symmetry 
       (toward uninvolved) –6.2 (17.6) –13.7 (15.2)* –9.9 (9.8) –8.37 (12.3)
Step-up/over
lift-up index (% BW > 100%) 41.0 (11.3) 45.0 (11.7)* 47.0 (11.3)* 47.3 (11.6)*
time (s) 1.49 (0.33)† 1.67 (0.69)* 1.51 (0.36) † 1.40 (0.26) †
impact (% BW) 47.6 (17.0)† 54.9 (18.2)* 54.1 (19.3)* 50.7 (16.9)
Forward lunge
distance (% height) 44.9 (7.1) 46.8 (19.1) 50.5 (19.0) 51.3 (23.8)
impact index (% BW) 24.4 (7.0)† 21.8 (6.7)* 24.4 (7.4) † 27.2 (10.4) †
time (s) 1.39 (0.43)† 1.51 (0.44)* 1.34 (0.28)† 1.29 (0.39)†
Patient-reported outcomes
 IKDC 38.43 (12.50) 41.62 (15.68) 51.10 (18.34)*† 56.21 (20.64) *†
SF-36 PCS 37.39 (8.79) 37.98 (9.83) 43.50 (9.16)*† 44.22 (11.28) *†
 Lysholm 47 (18) 54 (21) 61 (23) *† 65 (24) *†
 WOMAC 33 (17)† 28 (17)* 22 (19) *† 20 (19) *†
Abbreviations: BW, body weight; IKDC, International Knee Documentation Committee Subjective Knee Evaluation Form; SF-35 PCS, 36-Item 
Short-Form Health Survey Physical Component Scales; WOMAC, Western Ontario and McMaster Osteoarthritis Index. 
*Significantly different from preoperative time point. †Significantly different from 3-month time point.
Discussion
The primary purpose of this study was to provide a time-
line for recovery that could be used by both patients and 
clinicians in managing expectations regarding postop-
erative recovery of function. A summary timeline of the 
functional recovery observed in the fi rst year after ACI 
can be seen in Figure 6. Overall, these results suggest 
that patients may experience physical benefi ts such as 
decreased pain and symptoms as early as 3 months after 
ACI, but some facets of functional performance may 
initially decline after surgery, with signifi cant improve-
ments in functional performance of complex tasks such 
as squatting and stepping not occurring until 12 months, 
or perhaps longer.
Patient-Reported Outcomes
PROs have frequently been used to document functional 
outcomes after ACI.3–5 The observed results suggest that 
patients may experience functional improvements for 
simple activities of daily living such as those evaluated 
by the WOMAC as early as 3 months after ACI. However, 
data from the other self-reported outcome instruments 
used suggest that patients should not expect signifi cant 
improvement before the 6-month time point. The lack 
of signifi cant improvement in most PRO scores at the 
3-month time point is in agreement with previous research 
by Henderson and Levigne36 and Ebert et al23 However, 
those authors observed decreases in self-reported func-
tion using the IKDC36 and SF-36 PCS23,36 at the 3-month 
time point, while we observed slight but nonsignifi cant 
increases. In contrast, Tohyama et al37 reported signifi cant 
improvements in Lysholm scores as early as 3 months 
after treatment with atelocollagen-associated ACI.
The improvements observed among patients in 
IKDC, Lysholm, and SF-36 PCS scores at 6 months were 
similar to the outcomes observed by Niemeyer et al for 
the IKDC38 and both Niemeyer et al38 and Kreuz et al39
for the Lysholm. Other authors have observed even larger 
improvements in IKDC37 and Lysholm40 scores as early 
as 6 months after ACI.
Across all PROs we observed improvements when 
preoperative scores were compared with scores 12 
months after ACI surgery. These results are in agreement 
with the fi ndings of others when using IKDC,36,38,39,41–45
Lysholm,37–39,41,42 SF-36 PCS,36 and WOMAC46,47 scores 
1 year after ACI. Regardless of which outcome instrument 
is used, the IKDC, Lysholm, SF-36 PCS, or the WOMAC, 
both clinicians and patients can anticipate improvements 
in self-perceived function during the fi rst year after ACI.
Performance-Based Assessments
Limited improvements in PBAs were observed 1 year 
after ACI (Table 2.). In general, a decrease in physical 
performance was observed at 3 and 6 months postopera-
tively, followed by a return toward baseline at 12 months 
after ACI. This pattern of decreased function followed by 
gradual return/improvement of function was particularly 
true for the weight-bearing squat, step-up/over, and lunge. 
The only measures to show positive improvements from 
preoperative levels at or within the 12-month time period 
were walk-across stride length, sit-to-stand weight-shift 
time, and step-up/over lift-up index. These results sug-
gest that improvements for simpler, less demanding 
Figure 6 — Timeline of functional recovery after autologous chondrocyte implantation.
tasks such as walking or going up steps can be seen as 
early as 6 to 12 months after ACI. However, for more 
complex tasks, particularly those that require eccentric 
quadriceps control—such as squatting, going down steps, 
or lunging—meaningful changes in function may not be 
observed within the first year after ACI.
Decreases in physical performance at the 3-month 
time point have been previously observed with the 
6-minute-walk test after matrix-induced autologous 
chondrocyte implantation (MACI)23,25 and characterized 
chondrocyte implantation (CCI).24 Similar to our results, 
other researchers have observed slight improvements in 
walking performances at the 6-month25 and 12-month24,25 
time points that continued to improve at 24-month follow-
up.24,25 During laboratory gait analysis, improvements in 
gait speed and stride length, without significant changes 
in stride width, were observed over 12 months after 
MACI.48 These results support our observation that, after 
an initial decrease in function, patients and physicians 
can anticipate improvements in gait beginning around 
the 6-month time point after ACI.
In examining more-dynamic tasks, Van Assche et 
al28 observed deceased functional performance for a 
series of hopping and strength tasks (single-limb hop, 
crossover hop, 6-m timed hop, and isometric knee-
extension strength) at 6 months after CCI and no sig-
nificant improvements as late as 24 months after CCI. 
For example, those authors observed a 9% decrease in 
the single-leg-hopping limb-symmetry index through 
24 months after surgery. These results are in agreement 
with our observations demonstrating an initial decrease 
in function for more dynamic tasks such as squatting 
and stepping, with few or no significant or measurable 
improvements in functional performance at the 12-month 
time point after ACI.
In comparison with normative data49 it can be 
observed that some long-force-plate variables are below 
preoperative levels at baseline but approach or achieve 
age-group normative values during the first year of 
postoperative recovery. These include the step-up/over 
lift-up index and forward-lunge distance. However, other 
variables such as step-up/over and forward-lunge times 
are below normal at baseline, become more abnormal at 
the 3-month time point, and despite some improvement 
continue to be below normative levels at the 1-year mark. 
These results suggest that although patients may have 
improvements in the ability to successfully perform the 
task, they continue to do so at a slower pace.
Across the literature and within our study sample, 
improvements in gait relative to presurgery have been 
observed as early as 6 months after ACI.25 However, 
improvements in more-dynamic activities such as 
squatting, lunging, stepping, and hopping have not been 
observed within the first 12 months after ACI in the cur-
rent study or elsewhere.28 These results support existing 
theory that although improvements in self-report mea-
sures may occur early postoperatively, maximal defect 
healing and functional improvement continue beyond 12 
months after ACI.50–53
The occurrence of changes in self-report measures of 
function before changes in performance-based measures 
of function may be a result of the large influence that pain 
levels have been observed to have on PRO scores.19–22 The 
observed improvement in PRO scores in the absence of 
improved physical performance supports the importance 
of incorporating both types of outcome measures when 
documenting patient outcomes. The importance of a 
patient’s own rating of function and subjective feelings 
toward joint health cannot be ignored. However, when 
considering decisions such as ability to return to work 
or physical activity, or to evaluate postoperative changes 
in biomechanics, performance-based measures provide 
unique information that cannot be fully and accurately 
captured by PROs alone.
Limitations
A limitation of this study is the inclusion of a diverse 
ACI patient population. The study sample included indi-
viduals undergoing treatment for lesions to the patella, 
trochlea, and/or femoral condyle, many of whom also 
underwent concomitant realignment procedures. In 
addition, rehabilitation compliance was not tracked, and 
all patients were free to work with a physical therapist 
of their choice. Because of this variability, the presented 
timeline for recovery is not specific or precise for any 1 
defect location and/or realignment procedure. Instead, 
a broad pattern of recovery has been presented that can 
be generalized to a variety of defect patterns and sizes.
An additional limitation of this study is the lack of 
outcomes beyond 12 months post-ACI. However, the pur-
pose of this study was to provide a descriptive timeline for 
changes in self-perceived function and functional recov-
ery in the first year after ACI. This timeline is intended 
to describe when patients can expect improvements in 
activities of daily living and when they will perceive a 
benefit from the surgery, 2 key pieces of information that 
may be valuable to patients and physicians when decid-
ing if and when to undergo ACI. Future examination of 
these outcome variables for a longer period (>1 y) will 
provide more information regarding the long-term course 
of recovery after ACI.
Conclusions
This study presents a descriptive timeline for changes 
in both PROs and PBAs during the first 12 months after 
ACI. Self-perceived changes in function were observed 
as early as 3 months after ACI, while performance-based 
measures of function demonstrated functional deficits 
compared with preoperative levels at both the 3- and 
6-month time points. Specifically, patients demonstrated 
increased asymmetry of weight distribution when squat-
ting and rising from sitting, decreased vertical ground-
reaction-force production during lunging, and longer 
performance times for lunging and stepping activities. 
At the 12-month time point, performance improvements 
were seen for walking speed, sit-to-stand weight-transfer 
time, and step-up/over lift-up index; however, step-up/
over time and forward-lunge impact index and time 
remained below previously reported norms. Overall, it 
was observed that patients’ perceptions of functional 
improvements may outpace true physical changes in 
function. The present results, combined with those in 
the literature, provide important information for both 
physicians and rehabilitation specialists to consider when 
working with cartilage patients who desire to return to 
high-level physical activity. Clearly, recovery can be 
lengthy, and intense rehabilitation (beyond the existing 
standard of care) may be necessary to improve beyond or 
even restore to preoperative levels of dynamic function.
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